ライフサイエンスコーパス: blood sample

1 , 92% tested D816V-positive in the screening blood sample.

2 can perform these measurements from a minute blood sample.

3 free amino acids, were measured in collected blood samples.

4 L-like tumors, even noninvasively in routine blood samples.

5 despread use, already profiling over 400,000 blood samples.

6 signature transcript profiles in peripheral blood samples.

7 7)Lu-lilotomab satetraxetan concentration in blood samples.

8 erformance liquid chromatography analysis of blood samples.

9 DNA was isolated from blood samples.

10 ma-camera whole-body measurements along with blood samples.

11 and dose due to beta emissions (Dbeta) from blood samples.

12 luidic chip to successfully process complete blood samples.

13 l DNA markers were measured from participant blood samples.

14 Patients and controls provided venous blood samples.

15 HRPII from Plasmodium falciparum parasitized blood samples.

16 d results should be confirmed via testing of blood samples.

17 ficity are found with model and real patient blood samples.

18 l Population Cohort and obtained their whole-blood samples.

19 OxH-GO system can determine glucose level in blood samples.

20 so assessed by detecting norovirus in spiked blood samples.

21 electrochemical detection of HbA1c in human blood samples.

22 for the rapid detection of AIV H5N1 in whole blood samples.

23 ic mosaicism by validation studies in normal blood samples.

24 ver tissues (control tissues) and peripheral blood samples.

25 r spectroscopic features for female and male blood samples.

26 highly efficient detection of CWD prions in blood samples.

27 ng tumor cells (CTCs) from pretreatment SCLC blood samples.

28 in subjects with immediate centrifugation of blood samples.

29 ON1 expression in an independent set of cord blood samples.

30 se and 12 nonobese patients and obtained 294 blood samples.

31 enepuncture and finger-stick capillary whole-blood samples.

32 -B. anthracis bacterial isolates and patient blood samples.

33 180-min PET with (18)F-AV-1451 and arterial blood sampling.

34 bolus injection of (18)F-T807 with arterial blood sampling.

35 with intravenous (iv) catheters for repeated blood sampling.

36 n observational study that included frequent blood sampling.

37 ) from the early clamping group returned for blood sampling.

38 hemical data were collected within 7 days of blood sampling.

39 ne sufficiency during pregnancy in both heel blood samples [1.79 mIU/L (95% CI: 1.61, 1.97 mIU/L) com

40 I: 1.68, 1.82 mIU/L), respectively] and cord blood samples [11.91 mIU/L (95% CI: 6.67, 17.14 mIU/L) c

41 otal of 239 pregnant women were enrolled; 32 blood samples (13.4%) were positive, and 207 (86.6%) wer

42 Among 6751 HIV-negative HHCs with baseline blood samples, 192 had secondary tuberculosis disease du

43 en), with a mean age of 73 years, provided a blood sample; 2137 had no signs of AMD, 2209 had early A

44 Repeated blood samples (7) were drawn during 1-year follow-up.

45 Serial blood samples (a total of 6) were also obtained starting

46 boratory standard IMMULITE analyzer in whole blood samples, a correlation of 0.92 (P<0.0001) was obse

47 performed using a Sysmex XN-1000 analyser on blood samples acquired on the day of the thermal injury

48 the immune response to trauma have analysed blood samples acquired post-hospital admission.

49 ting tumor cells (CTCs) derived from patient blood samples after ex vivo expansion into CTC clusters.

50 From 108 blood samples analyzed from 36 patients, PV had signific

51 the probability of successfully obtaining a blood sample and the procedure completion time.

52 ent a clinical examination including fasting blood samples and a dual-energy X-ray absorptiometry sca

53 Blood samples and anthropometry measurements were collec

54 Blood samples and aspirates of pus from cutaneous nodule

55 uman immune and liver cells, human liver and blood samples and cell culture models of monocyte/macrop

56 -based deconvolution is typically applied to blood samples and has potentiated our understanding of t

57 f detection (LoD) for Borrelia spp. in whole blood samples and is able to detect B. burgdorferi in cl

58 minate (PCL) method that accepts eight whole blood samples and provides the capabilities to not only

59 as observed in 6 individuals with sequential blood samples and upon compartmental analysis of 1 patie

60 Blood samples and urine were collected at regular interv

61 addition, IDIF results obtained with venous blood samples and with a transformed venous-to-arterial

62 Full tracer kinetic models require arterial blood sampling and dynamic image acquisition.

63 of angioedema, activity (UAS at the time of blood sampling and for 7 days), quality of life (CU-Q2oL

64 A 90-min dynamic PET scan with arterial blood sampling and metabolite analysis was acquired for

65 erwent (18)F-DPA-714 PET scans with arterial blood sampling and metabolite analysis.

66 51 (T807) tau binding, including models with blood sampling and noninvasive alternatives.

67 ated hemoglobin were measured from a fasting blood sample, and 2-hour glucose was measured after an o

68 sitive result from the EMA tests in a second blood sample, and the presence of at least 1 symptom cou

69 eye examination including refraction, gave a blood sample, and were interviewed by trained fieldworke

70 Baseline characteristics, blood samples, and angiography information were obtained

71 s performed with a subset of placentas, cord blood samples, and buccal samples collected during the N

72 ough next-generation sequencing of saliva or blood samples, and RNA was extracted from fibroblasts cu

73 red blood cells (RBC) from prenatal maternal blood samples, and using HumanMethylation450 Bead Chips,

74 inical data were collected within 30 days of blood sampling, and biochemical data were collected with

75 Blood samples are easily collected by conventional venep

76 ne levels and species in patient and control blood samples as an indication of liver phosphatidyletha

77 955c (caprine blood) are not valid for human blood samples as the optimum initial sample amount for a

78 he monolithic CTC-iChip enables debulking of blood samples at 15-20 million cells per second while yi

79 (linoleic acid and arachidonic acid [AA]) in blood samples at age 8 years were measured for 940 child

80 glucose at concentrations typically found in blood samples at physiological conditions (pH 7.4).

81 Assessing peripheral blood samples at steady-state and during the acute respo

82 ndividuals who had donated two prediagnostic blood samples before B-cell lymphoma diagnosis, along wi

83 MPA obtained with combined body counting and blood sampling, blood measurements alone are sufficient

84 s the presence of bacterial DNA in incubated blood samples but also in negative controls, indicating

85 sCD23, sCD27, and sCD30 and lymphoma risk in blood samples collected 15 to 25 years before diagnosis.

86 concentrations [GMC] in mug/mL) measured in blood samples collected at 13 months of age.

87 nd serum PFOA concentration were measured in blood samples collected during 2005-2006.

88 nalyzing cumulative sequence data from 1,351 blood samples collected from 188 patients enabled us to

89 min D metabolites, and phosphate from paired blood samples collected from the abdominal aorta and ren

90 By contrast, blood samples collected in heparin tubes were adequate f

91 RNA-seq analysis of peripheral blood samples collected just prior to experimental chall

92 with the use of visual analog scales (VASs), blood samples collected, and ad libitum energy intake (E

93 rtant factors influencing time efficiency of blood sample collection.

94 is considered when allocating resources for blood sample collection.

95 Unlike plasma/tissue/blood samples, CSF requires minimal sample preparation:

96 cteristics to glucose determination in whole blood samples, discriminating among healthy and hypergly

97 c gene expression of IGF2, but 32.4% of cord blood samples displayed LOI of IGF2 and 10.8% showed ROI

98 l blood mononuclear cells were isolated from blood samples drawn directly before, as well as 5 minute

99 non-anthrax bacterial isolates or by testing blood samples drawn from patients with concurrent non-B.

100 files in nasopharyngeal (NP) swabs and whole blood samples during natural RSV and rhinovirus (hRV) in

101 nts contributed demographic data and up to 4 blood samples each from October 2009 to September 2010.

102 Superoxide dismutase (SOD) level in the blood samples expressed significant positive correlation

103 Serial fetal blood sampling (FBS) and intrauterine platelet transfusi

104 rt of an open study (n = 28; 69-92 years; 41 blood samples, five pretreatment scans, 19 post-treatmen

105 tomography-confirmed bronchiectasis provided blood samples for desmosine measurement, and 381 provide

106 Blood samples for DNA genotyping were collected from all

107 ive cells were isolated from NPs and matched blood samples for flow cytometric analysis.

108 ermined by monitoring body weight, analyzing blood samples for hematologic and renal toxicity (hemogl

109 ad quantitation, typing, and genotyping, and blood samples for transcriptome analyses were obtained w

110 neuropsychological battery, overnight hourly blood sampling for cortisol and genetic assessment.

111 lucose tolerance test with ECG recording and blood sampling for measurements of glucose, insulin, C-p

112 candidate genes were measured in peripheral blood sampled from ischemic stroke patients at emergency

113 Blood samples from 125 healthy Kenyan children were anal

114 Screening blood samples from 14 patients tested D816V-negative.

115 sessed global RNA expression levels in whole blood samples from 150 participants, representing patien

116 Microarray analysis was performed on blood samples from 150 subjects, of whom 30 were uninfec

117 T2MR detected B. burgdorferi in blood samples from 17/54 (31%) of patients with probable

118 n validation by collecting fingerprick whole blood samples from 20 participants to assess iron status

119 -positives were identified from 6,844 canine blood samples from 22 U.S. states, resulting in 229 B. c

120 we employed proteomics approaches to analyze blood samples from 263 individuals, 165 of them with DS,

121 We collected blood samples from 3 relatives with CRC in Spain (65, 62

122 ssed in 280 pretransplant and posttransplant blood samples from 33 desensitized patients who received

123 ation was 88% (71%-100%; 7113 questionnaires/blood samples from 3320 PWID).

124 dy, leukocytes were isolated from peripheral blood samples from 35 controls and 119 participants with

125 In a series of in vitro studies using blood samples from 37 participants, we found that sheddi

126 We collected blood samples from 42 patients with chronic HCV infectio

127 Screening blood samples from 44 of 58 patients tested D816V-positi

128 ippines, and DNAm was characterized in whole blood samples from 494 participants (age 20-22 y).

129 We collected bile and blood samples from 50 patients undergoing therapeutic en

130 We apply ichorCNA to 1439 blood samples from 520 patients with metastatic prostate

131 We tested blood samples from 755 HIV-uninfected adults with presum

132 on sequencing (NGS) data of paired tumor and blood samples from 8,810 individuals to assess the frequ

133 detected among longitudinal, intraindividual blood samples from 9 of 15 patients and in most of the p

134 To overcome this limitation, we examined blood samples from a controlled human malaria infection

135 say) analyses were performed on finger-prick blood samples from a population-based survey in 3 adjace

136 sters of pregnancy by using a subset of cord blood samples from a randomized, double-blind, placebo-c

137 In this study, we analyzed longitudinal blood samples from advanced stage non-small cell lung ca

138 We also obtained blood samples from anonymised waste material of age-and-

139 Clinical symptoms and peripheral blood samples from AR subjects were collected during NAC

140 expression was transiently reduced in whole blood samples from both omalizumab- and placebo-treated

141 We obtained blood samples from Cambodian patients infected with P fa

142 K DNA methylation analysis was performed on blood samples from clinical atherosclerosis patients (n

143 Finger-prick blood samples from consenting individuals of all ages pr

144 ort composed of a residential population and blood samples from forest service employees collected 15

145 Treatment of blood samples from hemorrhagic fever virus (HFV)-infecte

146 spectively applied large-scale proteomics to blood samples from ILLUMINATE (Investigation of Lipid Le

147 tergent treatment did not inactivate EBOV in blood samples from infected NHPs.

148 performed a whole-transcriptomic analysis of blood samples from Malian children with cerebral or unco

149 Cord blood samples from neonates born to mothers supplemented

150 Matched urine and finger-prick blood samples from participants >/=2 years of age with f

151 Peripheral blood samples from patients with ALF had a higher propor

152 eri was detected using T2MR in 2/2 (100%) of blood samples from patients with confirmed early LD, bas

153 We analyzed blood samples from patients with HCV-CV before and after

154 Moreover, Hdac1 levels are increased in blood samples from patients with schizophrenia who had e

155 e obtained skin biopsies and contemporaneous blood samples from patients within 24 hours of onset of

156 We assayed blood samples from SB polar bears to assess prior exposu

157 We collected blood samples from study participants every 6 months and

158 tion nucleotide sequencing data derived from blood samples from study patients.

159 tes, blood glucose, and urea levels in whole blood samples from thick blood films on glass slides.

160 ew method to predict metastasis by screening blood samples from xenograft models, showing that upon C

161 In each case, the key blood sample had high cell-associated viral loads withou

162 andard, a test for NK cell activity in whole blood samples identified patients with CRC with 87.0% se

163 that a D816V-positive result in a screening blood sample identifies SM among patients with hymenopte

164 l responses were undetectable in the primary blood sample in which infection was detected, EBV-specif

165 Sensitization was assessed from blood samples in 3293 children.

166 unodeficiency virus (HIV)-negative HHCs with blood samples in whom tuberculosis disease developed >/=

167 not affected by 0.1% detergent treatment of blood samples, in contrast with 1% SDS treatment.

168 ood collection and timely shipment of labile blood samples is difficult.

169 l aging (measured using epigenetic data from blood samples) is correlated with reduced integrity of w

170 zing 320 methylated genes from 26 studies on blood samples (N = 17,675), we found 57 enriched pathway

171 R to measure relative telomere length in 389 blood samples (n = 318 individuals) collected from an un

172 Serial pre- and postfilter blood samples (n = 4 each) were drawn and analyzed for g

173 0.6 +/- 0.4% of CD45(+) events from matched blood samples (n = 5) were OSM(+), suggesting that incre

174 cal tests of micronutrient levels from whole blood samples (n=95) show comparable sensitivity and spe

175 From the blood samples, Na, P, S, Cl, K, Ca, Fe, Cu, Zn, and Br e

176 Our findings reveal that, compared with heel blood samples, neonatal thyrotropin in samples collected

177 All participants underwent collection of blood samples, neuropsychological assessment, and 3-T MR

178 in which we compared measurements from whole-blood samples obtained by venapuncture with measurements

179 C4a, C5a, and SC5b-9 levels were measured in blood samples obtained during the 96-hour observation pe

180 t allergic reactions using serial peripheral blood samples obtained from 19 children before, during,

181 of HIV RNA in single HIV-infected cells from blood samples obtained from individuals with viremia or

182 ubjects were imaged for 3.5 h, with arterial blood samples obtained throughout.

183 Blood samples of 3 patients with severe G6PD deficiency

184 lism and transulfuration pathways taken from blood samples of 83 participants with ASD and 76 age-mat

185 blood, with significantly higher numbers in blood samples of MM patients in remission (20-24 CD138(+

186 The clinical implication was studied in blood samples of patients with inflammatory bowel diseas

187 arize technologies used to isolate CTCs from blood samples of patients with pancreatic cancer, includ

188 tected clonal haemopoiesis in the peripheral blood samples of ten (71%) patients.

189 than of controls (median, 1.31% vs 2.32% for blood samples, P = .0048; and median, 4.34% vs 13.40% fo

190 ted to the mf densities in the corresponding blood samples (r = 0.53 and P = 0.008 for polyclonal ass

191 Screening of newborn blood samples revealed a significantly higher prevalence

192 attenuated ETEC strain, and collected serial blood samples shortly after inoculation and daily for 8

193 RNA-Seq analysis of serial blood samples showed different routes led to the same ov

194 We collected fasting blood samples, socio-demographic information, physical m

195 a in a biological sample, for example, a rat blood sample spiked with E. coli.

196 monly used gene expression measurements from blood samples suffer from variability of cell compositio

197 neoepitopes after isolation of cells from a blood sample taken almost 3 years after the tumors were

198 iations with IL-6 and IL-8 were observed for blood samples taken close to diagnosis (<5 years) as wel

199 he host response to pathogen infection using blood samples taken during an outbreak situation can pro

200 Blood samples taken from a guinea pig model of IA were u

201 (68)Ga-DOTA-E-[c(RGDfK)](2) radiotracer and blood-sample tests to quantify angiogenesis factors (fib

202 Using 100 microl finger-prick blood samples, the Cepheid Xpert HIV-1 Viral Load and HI

203 In peripheral blood samples, the device detected a baseline of 2-5 CD1

204 We perform experiments flowing blood samples through a microfluidic channel coated with

205 odes, livers, brown fat samples, kidneys, or blood samples throughout the 28-day experiment.

206 Individuals provided a finger-blood sample to assess malaria infection by microscopy a

207 lood typing system using a small quantity of blood sample to determine the degree of agglutination of

208 g of 32 genes on the pretreatment peripheral blood samples to detect clonal haemopoiesis.

209 ssure, waist circumference (WC), and fasting blood sample (total cholesterol, high-density lipoprotei

210 ere monitored for parasite clearance (50 muL blood samples twice daily at 12 h intervals until two co

211 ime (TAT) was measured in business days from blood sampling until test reporting.

212 o compare the D816V status of the "screening blood sample" used to guide BM biopsy in suspected SM to

213 f-origin of tumor-derived cell-free DNA in a blood sample using genome-wide DNA methylation data.

214 Thymic function was quantified in peripheral blood samples using the sj/beta-TREC ratio.

215 study has been performed to analyze clinical blood samples using this technology, demonstrating its p

216 For each patient, a peripheral blood sample was collected at baseline for the evaluatio

217 A blood sample was collected, a clinical questionnaire abo

218 A venous blood sample was taken at baseline and at 6 and 12 mo.

219 A larger blood sample was taken before and 1 h after consumption

220 An elevated chymase level in acute phase blood samples was highly indicative of later diagnosis o

221 ement between KECG and reference [K(+)] from blood samples was promising (error: -0.09 +/- 0.59 mM, a

222 a dynamic (18)F-FHNP PET scan with arterial blood sampling was acquired from rats treated with vehic

223 Serial blood sampling was performed to quantify manganese and g

224 festyle factors, disease history and fasting blood sample were collected.

225 ty score (ISS) of 24 (range 9-66), from whom blood samples were acquired within 1 hour of injury (mea

226 One-milliliter blood samples were added to the filter-based detection c

227 Blood samples were also obtained to verify for the prese

228 Blood samples were analysed for inflammatory biomarkers.

229 Blood samples were analyzed for complete blood count, se

230 A total of 34 blood samples were analyzed with microfluidic photo trea

231 At the time of amniocentesis, maternal blood samples were collected and analyzed by means of re

232 Blood samples were collected and data on smoking, hormon

233 Fasting blood samples were collected and plasma was analyzed by

234 Blood samples were collected at 4, 8, and 16 years of ag

235 Blood samples were collected at ages 2, 4, 6, and 11 yea

236 Blood samples were collected at baseline and 16 weeks, a

237 Blood samples were collected at baseline and at an early

238 oeconomic data, anthropometric measures, and blood samples were collected at baseline and endline.

239 nzyme-linked immunospot (IFN-gamma ELISPOT), blood samples were collected at baseline, post-doses 2,

240 r GP of SM was administrated to subjects and blood samples were collected at predetermined time point

241 Blood samples were collected at routine clinical appoint

242 Non-fasting blood samples were collected at the ages of 1, 1.5, 2, 3

243 Fasting blood samples were collected at the end of each sodium i

244 Blood samples were collected before and after apixaban a

245 Blood samples were collected before the influenza season

246 Blood samples were collected before vaccination and up t

247 Small-volume blood samples were collected by finger stick at twice-we

248 Blood samples were collected during the 12-h postprandia

249 Information and blood samples were collected every 2 months.

250 Blood samples were collected every 3 months between 3 an

251 Urine and blood samples were collected for biomarker measurements

252 Fasted venous blood samples were collected for iron isotopic analysis

253 Blood samples were collected from 103 patients undergoin

254 Blood samples were collected from 109 BD patients and 36

255 Baseline blood samples were collected from 24 HIV-infected antire

256 Blood samples were collected from 476 individuals and an

257 Blood samples were collected from 62 Mexican patients wi

258 At 24 weeks, blood samples were collected from offspring mice for lip

259 Plasma and finger-stick capillary whole-blood samples were collected from participants in an obs

260 Lung tissues and blood samples were collected from rats at 4, 32, and 44

261 Blood samples were collected from these patients before

262 Blood samples were collected in 1989-1990 (Nurses' Healt

263 Twenty-two follow-up blood samples were collected in BD patients.

264 Blood samples were collected on the day of colonoscopy,

265 Urine, saliva and blood samples were collected over the first 12 months of

266 Muscle biopsies and blood samples were collected to assess muscle protein sy

267 Arterial blood samples were collected to calculate the metabolite

268 Fasting blood samples were collected to estimate lipid profile.

269 At weeks 0 and 6, stool, urine and blood samples were collected, and functional magnetic re

270 Blood samples were collected, and standard vital signs (

271 effects, vital signs were obtained, fasting blood samples were collected, and the Adherence Estimato

272 nical history and symptoms were assessed and blood samples were collected.

273 ions, indirect calorimetry was performed and blood samples were collected.

274 Blood samples were drawn at both times to assess CEC and

275 Arterial blood samples were drawn for arterial input function det

276 Blood samples were drawn on days 0, 1, 3, and 7, and SIR

277 In addition, blood samples were drawn to assess cholesterol efflux ca

278 ical and dental history of participants, and blood samples were drawn to determine Abeta levels using

279 Archival tumor and blood samples were genotyped for somatic and germline mu

280 Whole-blood samples were obtained at the acute and early conva

281 Blood samples were obtained before the meal and 0.5, 1,

282 Peripheral blood samples were obtained for HIV antibody testing.

283 With informed consent, blood samples were obtained from 50 patients before and

284 METHODS AND Endomyocardial biopsies and blood samples were obtained from patients with newly dia

285 Blood samples were obtained on admission, 24 hours post-

286 , and 48 hours from (last) dosing, patients' blood samples were supplemented with concentrated platel

287 Blood samples were taken at different times after inject

288 Blood samples were taken before and after the interventi

289 Blood samples were taken from 100 confirmed HIV infected

290 Fasting blood samples were taken from a subgroup (placebo, n = 3

291 Blood samples were taken from uncontrolled diabetic pati

292 Blood samples were tested for serologic evidence of CD.

293 Serum and whole-blood samples were treated with 0.1% or 1% sodium dodecy

294 Biomarker shedding was monitored by serial blood sampling, whereas tumor viability and volume were

295 d solutions of several metal salts and human blood samples (whole blood, blood serum, blood plasma, a

296 ultiple biomarker measurements from a single blood sample with electronic medical record data (EMR) f

297 Treatment of blood samples with 0.1% SDS or Triton X-100 does not ina

298 detecting sickle hemoglobin (HbS) in newborn blood samples with a limit of detection of 2% HbS.

299 binate biopsy samples, 19.5% (22 of 113) for blood samples, with seropositivity of 62.8% (71 of 113 s

300 ulture of immune cells from the same patient blood sample within specially designed microwells that p